Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2005-07-01
2011-10-25
Vogel, Nancy (Department: 1636)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C435S440000
Reexamination Certificate
active
08043842
ABSTRACT:
The present invention provides a bacterium having a genome that is genetically engineered to be at least 2 to 14% smaller than the genome of its native parent strain. A bacterium with a smaller genome can produce a commercial product more efficiently. The present invention also provides methods for deleting genes and other DNA sequences from a bacterial genome. The methods provide precise deletions and seldom introduces mutations to the genomic DNA sequences around the deletion sites. Thus, the methods can be used to generate a series of deletions in a bacterium without increasing the possibility of undesired homologous recombination within the genome. In addition, some of the methods provided by the present invention can also be used for replacing a region of a bacterial genome with a desired DNA sequence.
REFERENCES:
patent: 4851348 (1989-07-01), Hanahan
patent: 4981797 (1991-01-01), Jessee et al.
patent: 5578464 (1996-11-01), Lunn et al.
patent: 5747662 (1998-05-01), Simmons et al.
patent: 5824502 (1998-10-01), Honjo et al.
patent: 5962327 (1999-10-01), Dujon et al.
patent: 6015709 (2000-01-01), Natesan
patent: 6022952 (2000-02-01), Weiner et al.
patent: 6117680 (2000-09-01), Natesan et al.
patent: 6238924 (2001-05-01), Dujon et al.
patent: 6335178 (2002-01-01), Weiner et al.
patent: 6372476 (2002-04-01), Belguith et al.
patent: 6410273 (2002-06-01), Crouzet et al.
patent: 6509156 (2003-01-01), Stewart et al.
patent: 6989265 (2006-01-01), Blattner et al.
patent: 2003/0138937 (2003-07-01), Blattner et al.
patent: 2005/0032225 (2005-02-01), Blattner et al.
patent: 0177343 (1986-04-01), None
patent: 0283726 (1988-09-01), None
patent: WO 96/14408 (1976-05-01), None
patent: WO 88/05821 (1988-08-01), None
patent: WO 01/27258 (2001-04-01), None
patent: WO 02/14495 (2002-02-01), None
patent: WO 03/048374 (2003-06-01), None
patent: WO 03/070880 (2003-08-01), None
patent: WO 2005/087940 (2005-08-01), None
Smalley et al, Trends in Microbiology, 11, (1), 6-8, 2003).
Asai et al., “AnEscherichia colistrain with all chromosomal rRNA operons inactivated: complete exchange of rRNA genes between bacteria,”Proc. Natl. Acad. Sci., USA, 96:1971-1976, 1999.
Balbas, “Understanding the art of producing protein and non-protein molecules inE. coli,”Molec Biotechnol., 19:251-267, 2001.
Baneyx, “Recombinant protein expression inE. coli,”Curr Opin Biotech, 10:411-421, 1999.
Bass et al., “Multicopy suppressors of Prc mutangEscherichia coliinclude two HtrA (DegP) protease homologs (HhoAB), DksA, and a truncated RlpA,”Journal of Bacteriology, 178(4):1154-1164, 1996.
Beaulieu et al., “Pathogenic behavior of pectinase-defectiveErwinia chrysanthemimutants on different plants,”MPMI, 6(2):197-202, 1993.
Berry et al., “Application of metabolic engineering to improve both production and use of biotech indigo,”J Indust Micro&Biotech, 22:127-133, 2002.
Blattner et al., “The complete genome sequence ofEscherichia coliK-12,”Science, 277:1453-1474, 1997.
Blaudeck et al., “Specificity of single peptide recognition in TAT-dependent bacterial protein translocation,”J. Bacteriology, 183:604-610, 2001.
Court et al., “Genetic engineering using homologous recombination,”Annu Rev Genet, 36:361-388, 2002.
Current Protocols in Molecular Biology, 16.6.1-16.6.14, John Wiley and Sons, 1994.
Danese et al., “Targeting and assembly of periplasmic and outer-membrane proteins inEscherichia coli,”Annu Rev Genet, 32:59-64, 1998.
Datsenko et al., “One-step inactivation of chromosomal genes inEscherichis coliK-12 using PCR products,”Proc. Natl. Acad. Sci., USA, 97:6640-6649, 2000.
Degryse, “Evaluation ofEscherichia colirecBC sbcBC mutants for cloning by recombination in vivo,”J. Biotechnology, 39:181-187, 1995.
DeLisa et al., “Quorum sensing cia AI-2 communicates the metabolic burden associated with heterologous protein production inE. coli,”Biotech Bioeng, 75(4):439-450, 2001.
Dykstra and Kushner, “Physical characterization of the cloned protease III gene fromEscherichia coliK-12,”Journal of Bacteriology, 163(3): 1055-1059, 1985.
Eichhorn et al., “Deletion analysis of theEscherichia colitaurine and alkanesulfonate transport systems,”Journal of Bacteriology, 182(10)2687-2695, 2000.
Feher et al., “Engineering a reducedEscherichia coligenome,” Conference Abstract, Sep. 11, 2002.
Fekkes et al., “Protein targeting to the bacterial cytoplasmic membrane,”Microbiol. Mol. Biol. Rev., 63:161-193, 1999.
Gill et al., “A comparative study of global stress gene regulation in response to overexpression of recombinant proteins inE. coli,”Metabolic Engineering, 2:178-189, 2000.
Hanahan et al., “Studies on Transformation ofEscherichia coliwith plasmids,”J. Mol. Biol., 166(4):557-580, 1983.
Hannig, “Strategies for optimizing heterologous protein expression inEscherichia coli,”Trends Biotechnol., 16(2):54-60, 1998.
Hayashi et al., “Construction of a genetic linkage map of the model legumLotus japonicususing an intraspecific F2 population,”DNA Research, 8:11-22, 2001.
Hockney, “Recent developments in heterologous protein production inEscherichia coli,” Trends Biotechnol., 12(11):456-632, 1994.
Hynds et al., “The sec-independent twin-arginine translocation system can transport both tightly folded and malfolded proteins across the thylakoid membrane,”J. Biol. Chem., 273:34868-34874, 1998.
Kitamura, “DNA sequence changes in mutations in the ton B gene on the chromosome ofEscherichia coliK-12: insertion elements dominate the spontaneous spectra,,”Jpn J. Genet, 70:35-46, 1995.
Kolisnychenko et al., “Engineering a reducedEscherichia coligenome,”Genome Research, 12:640-647, 2002.
Koob et al., “Minimizing the genome ofEscherichia coli,” Ann NY Acad Science, 745:1-3, 1994.
Koonin, “How many genes can make a cell: the minimal-gene-set concept,”Ann Rev Genome Hum Genet, 1:99-116, 2000.
Lee, “High cell-density culture ofEscherichia coli,”TIBTECH, 14:98-103, 1996.
Murphy, “Use of bacteriophage λ recombination functions to promote gene replacement inEscherichia coli,” J. Bacteriol., 180:2063-2071, 1998.
Muyrers et al., “Rapid modification of bacterial artifical chromosomes by ET-recombination,”Nucleic Acids Research, 27:1555-1557, 1999.
Neidhardt et al., “Culture medium for Enterobacteria,”J. Bacteriol., 119:736-747, 1974.
Oliner et al., “In vivo cloning of PCR products inE. coli,” Nucleic Acids Research, 2(22):5192-5197, 1993.
Otto et al., “Surface sensing and adhesion ofE. colicontrolled by the Cpx-signaling pathway,”Proc. Natl. Acad. Sci., USA, 99(4):2287-2292, 2002.
Park et al., “MppA, a perplasmic binding protein essential for import of the bacterial cell wall peptide L-Ananyl-γ-D-glutamyl-meso-diaminopimelate,”Journal of Bacteriology, 180(5):1215-1223, 1998.
Perna et al., “Genome sequence of enterhemorrhagicEscherichia coliO157:H7,”Nature, 409:529-533, 2001.
Perna et al., “The genomes ofEscherichia coliK-12 and pathogenicE. coli,” Pathogenic E. coli Paradigm for Bacterial Pathogenesis, M.S. Donnenberg, Editor, Academmic Press, 2002.
Pfeifer et al., “Biosynthesis of complex polyketides in metabolically engineered strain ofE. coli,” 291:1790-1792, 2001.
Posfai et al., “In vivo excision and amplification of large segments of theEscherichis coligenome,”Nucleic Acids Research, 22(12):2392-2398, 1994.
Posfai et al., “Markerless gene replacement inEscherichia colistimulated by a double-strand break in the chromosome,”Nucleic Acids Research, 27:4409-4415, 1999.
Posfai et al., “Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE
Blattner Frederick R.
Glasner Jeremy D.
Herring Christopher D.
Plunkett Guy
Posfai Gyorgy
Fulbright & Jaworski
Vogel Nancy
Wisconsin Alumni Research Foundation
LandOfFree
Bacteria with reduced genome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacteria with reduced genome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacteria with reduced genome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4301908